HomePBYI • NASDAQ
add
Puma Biotechnology Inc
Previous close
$5.59
Year range
$2.58 - $6.12
Market cap
281.69M USD
Avg Volume
584.93K
P/E ratio
7.54
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 54.48M | -32.36% |
Operating expense | 32.73M | 11.45% |
Net income | 8.84M | -56.47% |
Net profit margin | 16.23 | -35.67% |
Earnings per share | 0.21 | -53.33% |
EBITDA | 12.30M | -50.74% |
Effective tax rate | 4.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 94.39M | -2.42% |
Total assets | 202.86M | -8.09% |
Total liabilities | 87.59M | -41.46% |
Total equity | 115.27M | — |
Shares outstanding | 50.39M | — |
Price to book | 2.44 | — |
Return on assets | 12.03% | — |
Return on capital | 15.43% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 8.84M | -56.47% |
Cash from operations | 9.69M | -12.22% |
Cash from investing | 506.00K | 95.37% |
Cash from financing | -11.33M | -1.33% |
Net change in cash | -1.14M | -1,097.37% |
Free cash flow | 6.59M | 89.09% |
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
172
